Quetiapine Fumarate
Average across 20 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| ScieGen Pharmaceuticals, Inc. | unknown | 15 | SUPPLYING |
| Aurobindo Pharma Limited | unknown | 15 | SUPPLYING |
| ACI Healthcare USA, Inc. | unknown | 5 | SUPPLYING |
| Golden State Medical Supply, Inc. | unknown | 5 | SUPPLYING |
| Major Pharmaceuticals | unknown | 5 | SUPPLYING |
| Lupin Pharmaceuticals, Inc. | unknown | 5 | SUPPLYING |
| AlignScience Pharma Inc. | unknown | 4 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | unknown | 1 | SUPPLYING |
| St. Mary's Medical Park Pharmacy | unknown | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets. — Recalling firm: The Harvard Drug Group — Nationwide
Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets. — Recalling firm: The Harvard Drug Group — Nationwide
Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets. — Recalling firm: The Harvard Drug Group — Nationwide
Labeling; Incorrect or Missing Package Insert: Product was packaged with the package insert for Quetiapine Fumarate Tablets not Quetiapine Fumarate Extended-Release Tablets. — Recalling firm: The Harvard Drug Group — Nationwide
Pill